Skip to main content

Advertisement

Log in

Antitumor effects of the flavone chalcone: inhibition of invasion and migration through the FAK/JNK signaling pathway in human gastric adenocarcinoma AGS cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Chalcones (benzylideneacetophenone) are cancer-preventive food components found in a human diet rich in fruits and vegetables. In this study, we first report the chemopreventive effect of chalcone in human gastric adenocarcinoma cell lines: AGS. The results showed that chalcone could inhibit the abilities of the adhesion, invasion, and migration by cell–matrix adhesion assay, Boyden chamber invasion/migration assay, and wound-healing assay. Molecular data showed that the effect of chalcone in AGS cells might be mediated via sustained inactivation of the phosphorylation of focal adhesion kinase (FAK) and c-Jun N-terminal kinase 1 and 2 (JNK1/2) signal involved in the downregulation of the expressions of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). Next, chalcone-treated AGS cells showed tremendous decrease in the phosphorylation and degradation of inhibitor of kappaBα (IκBα), the nuclear level of NF-κB, and the binding ability of NF-κB to NF-κB response element. Furthermore, treating FAK small interfering RNA (FAK siRNA) and specific inhibitor for JNK (SP600125) to AGS cells could reduce the phosphorylation of JNK1/2 and the activity of MMP-2 and MMP-9. Our results revealed that chalcone significantly inhibited the metastatic ability of AGS cells by reducing MMP-2 and MMP-9 expressions concomitantly with a marked reduction on cell invasion and migration through suppressing and JNK signaling pathways. We suggest that chalcone may offer the application in clinical medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1–9

    Article  PubMed  Google Scholar 

  2. Serafini M, Bellocco R, Wolk A, Ekstrom AM (2002) Total antioxidant potential of fruit and vegetables and risk of gastric cancer. Gastroenterology 123:985–991

    Article  CAS  PubMed  Google Scholar 

  3. Donaldson MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3:19

    Article  PubMed Central  PubMed  Google Scholar 

  4. Duthie G, Crozier A (2003) Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care 3:447–451

    Article  Google Scholar 

  5. Dimmock JR, Elias DW, Beazely MA, Kandepu NM (1999) Bioactivities of chalcones. Curr Med Chem 6:1125–1149

    CAS  PubMed  Google Scholar 

  6. Go ML, Wu X, Liu XL (2005) Chalcones: an update on cytotoxic and chemoprotective properties. Curr Med Chem 12:481–499

    Article  CAS  PubMed  Google Scholar 

  7. Tabata K, Motani K, Takayanagi N, Nishimura R, Asami S, Kimura Y, Ukiya M, Hasegawa D, Akihisa T, Suzuki T (2005) Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells. Biol Pharm Bull 28(2005):1404–1407

    Article  CAS  PubMed  Google Scholar 

  8. Kimura Y, Baba K (2003) Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol. Int J Cancer 106:429–437

    Article  CAS  PubMed  Google Scholar 

  9. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516–523

    Article  CAS  PubMed  Google Scholar 

  10. Stupack D (2007) The biology of integrins. Oncology 21:6–12

    PubMed  Google Scholar 

  11. van Nimwegen MJ, van de Water B (2007) Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73:597–609

    Article  PubMed  Google Scholar 

  12. Filder IJ (2005) The organ microenvironment and cancer metastasis. Differentiation 70:498–505

    Google Scholar 

  13. Shih YW, Chen PS, Wu CH, Jeng YF, Wang CJ (2007) α-Chaconine- reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-κB in human lung adenocarcinoma A549 cells. J Agric Food Chem 55:11035–11043

    Article  CAS  PubMed  Google Scholar 

  14. Khwaja A (1999) Akt is more than just a bad kinase. Nature 401:33–34

    Article  CAS  PubMed  Google Scholar 

  15. Chan-Hui PY, Weaver R (1998) Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades. Biochem J 336:599–609

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Trusolino L, Comoglio PM (2002) Scatter-factor and semaphoring receptors: cell signalling for invasive growth. Nat Rev Cancer 2:289–300

    Article  CAS  PubMed  Google Scholar 

  17. Chen PN, Hsieh YS, Chiou HL, Chu SC (2005) Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem Biol Interact 156:141–150

    Article  CAS  PubMed  Google Scholar 

  18. Kwon GT, Cho HJ, Chung WY, Park KK, Moon A, Park JH (2009) Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 20:663–676

    Article  CAS  PubMed  Google Scholar 

  19. Lee SJ, Park SS, Lee US, Kim WJ, Moon SK (2008) Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 8:1821–1826

    Article  CAS  PubMed  Google Scholar 

  20. Kajanne R, Miettinen P, Mehlem A, Leivonen SK, Birrer M, Foschi M, Kähäri VM, Leppä S (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol 212:489–497

    Article  CAS  PubMed  Google Scholar 

  21. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491–21494

    Article  CAS  PubMed  Google Scholar 

  22. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781–792

    CAS  PubMed  Google Scholar 

  23. Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43–52

    Article  CAS  PubMed  Google Scholar 

  24. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immuol 18:621–663

    Article  CAS  Google Scholar 

  25. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225

    Article  CAS  PubMed  Google Scholar 

  26. Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC, Lee IS (2007) Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem Biophys Res Commun 354:165–171

    Article  CAS  PubMed  Google Scholar 

  27. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  CAS  PubMed  Google Scholar 

  28. Ochi Y, Atsumi S, Aoyagi T, Umezawa K (1993) Inhibition of tumor cell invasion in the Boyden chamber assay by a mannosidase inhibitor, mannostatin A. Anticancer Res 13:1421–1424

    CAS  PubMed  Google Scholar 

  29. Morrow WJ, Yang YW, Sheikh NA (2004) Immunobiology of the tomatine adjuvant. Vaccine 22:2380–2384

    Article  CAS  PubMed  Google Scholar 

  30. Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW, Whang EE (2004) Prostaglandin E2 enhances pancreatic cancer invasiveness throughan Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res 64:7439–7446

    Article  CAS  PubMed  Google Scholar 

  31. Ma W, Lim W, Gee K, Aucoin S, Nandan D, Kozlowski M, Diaz-Mitoma F, Kumar A (2001) The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide stimulated human macrophages. J Biol Chem 276:13664–13674

    CAS  PubMed  Google Scholar 

  32. Sliva D (2004) Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4:327–336

    Article  CAS  PubMed  Google Scholar 

  33. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, Fan ST (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12:5369–5376

    Article  CAS  PubMed  Google Scholar 

  34. Parsons JT (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116:1409–1416

    Article  CAS  PubMed  Google Scholar 

  35. Fujii T, Koshikawa K, Nomoto S, Okochi O, Kaneko T, Inoue S (2004) Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol 41:104–111

    Article  CAS  PubMed  Google Scholar 

  36. Mukhopadhyay NK, Gordon GJ, Chen CJ, Bueno R, Sugarbaker DJ, Jaklitsch MT (2005) Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events. J Cell Mol Med 9:387–397

    Article  CAS  PubMed  Google Scholar 

  37. Akasaka T, van Leeuwen RL, Yoshinaga IG, Mihm MC, Byers HH (1995) Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol 105:104–108

    Article  CAS  PubMed  Google Scholar 

  38. Owens LV, Xu L, Craven RG, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG (1995) Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55:2752–2755

    CAS  PubMed  Google Scholar 

  39. Weiner TM, Liu ET, Craven RJ, Cance WG (1993) Expression of focal adhesion kinase gene and invasive cancer. Lancet 342:1024–1025

    Article  CAS  PubMed  Google Scholar 

  40. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T (1999) FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 274:10566–10570

    Article  CAS  PubMed  Google Scholar 

  41. Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117:4619–4628

    Article  CAS  PubMed  Google Scholar 

  42. John A, Tuszynski G (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7:14–23

    Article  CAS  PubMed  Google Scholar 

  43. Lee YS, Kim YH, Shin EK, Kim DH, Lim SS, Lee JY, Kim JK (2010) Anti-angiogenic activity of methanol extract of Phellinus linteus and its fractions. J Ethnopharmacol 131:56–62

    Article  PubMed  Google Scholar 

  44. Xu P, Zhang XX, Miao C, Fu Z, Li Z, Zhang G, Zheng M, Liu Y, Yang L, Wang T (2013) Promotion of Melanoma Cell Invasion and Tumor Metastasis by Microcystin-LR via Phosphatidylinositol 3-Kinase/AKT Pathway. Environ Sci Technol 47:8801–8808

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Research Program of Kaohsiung Armed Forces General Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuan-Wei Shih.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, SH., Shih, YW. Antitumor effects of the flavone chalcone: inhibition of invasion and migration through the FAK/JNK signaling pathway in human gastric adenocarcinoma AGS cells. Mol Cell Biochem 391, 47–58 (2014). https://doi.org/10.1007/s11010-014-1986-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-014-1986-6

Keywords

Navigation